Insider Transactions in Q4 2024 at Madrigal Pharmaceuticals, Inc. (MDGL)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2024
|
Fred B Craves Director |
SELL
Open market or private sale
|
Indirect |
3,600
-12.8%
|
$1,134,000
$315.55 P/Share
|
|
Nov 25
2024
|
Fred B Craves Director |
SELL
Open market or private sale
|
Indirect |
3,400
-9.91%
|
$1,190,000
$350.39 P/Share
|
|
Nov 21
2024
|
Carole Huntsman Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
688
-6.0%
|
$217,408
$316.92 P/Share
|
|
Nov 07
2024
|
Richard S Levy |
SELL
Open market or private sale
|
Direct |
5,000
-31.23%
|
$1,750,000
$350.0 P/Share
|
|
Nov 07
2024
|
Richard S Levy |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+23.8%
|
$35,000
$7.36 P/Share
|
|
Nov 01
2024
|
Richard S Levy |
SELL
Open market or private sale
|
Direct |
5,000
-8.77%
|
$1,505,000
$301.97 P/Share
|
|
Nov 01
2024
|
Richard S Levy |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+23.8%
|
$35,000
$7.36 P/Share
|